Your browser doesn't support javascript.
loading
Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand.
Hayman, D T S; Marshall, J C; French, N P; Carpenter, T E; Roberts, M G; Kiedrzynski, T.
Affiliation
  • Hayman DTS; (m)EpiLab, Infectious Diseases Research Centre, Massey University, Palmerston North 4442, New Zealand. Electronic address: D.T.S.Hayman@massey.ac.nz.
  • Marshall JC; (m)EpiLab, Infectious Diseases Research Centre, Massey University, Palmerston North 4442, New Zealand.
  • French NP; (m)EpiLab, Infectious Diseases Research Centre, Massey University, Palmerston North 4442, New Zealand.
  • Carpenter TE; EpiCentre, Infectious Diseases Research Centre, Massey University, Palmerston North 4442, New Zealand.
  • Roberts MG; Infectious Diseases Research Centre, Institute of Natural & Mathematical Sciences, New Zealand Institute for Advanced Study, Massey University, Private Bag 102 904, North Shore Mail Centre, Auckland, New Zealand.
  • Kiedrzynski T; Ministry of Health, Wellington, New Zealand.
Vaccine ; 35(37): 4913-4922, 2017 09 05.
Article in En | MEDLINE | ID: mdl-28802754
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization / Vaccination / Cost-Benefit Analysis / Measles Type of study: Health_economic_evaluation Limits: Humans Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2017 Document type: Article Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization / Vaccination / Cost-Benefit Analysis / Measles Type of study: Health_economic_evaluation Limits: Humans Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2017 Document type: Article Country of publication: Países Bajos